Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-13 11:08 am Sale | 13G | LIGAND PHARMACEUTICALS INC LGND | RENAISSANCE TECHNOLOGIES LLC | 1,021,189 5.81% | -459,630 (-31.04%) | View |
| 2020-02-12 4:05 pm Unchanged | 13G | SEELOS THERAPEUTICS INC PA SEEL | LIGAND PHARMACEUTICALS INC LGND | 2,224,000 8.1% | 0 (Unchanged) | View |
| 2020-02-12 08:09 am Sale | 13G | LIGAND PHARMACEUTICALS INC LGND | VANGUARD GROUP INC | 1,570,013 8.93% | -359,837 (-18.65%) | View |
| 2020-02-10 12:01 pm Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | WILLIAM BLAIR INVESTMENT MANAGEMENT LLC | 1,416,850 8.1% | 437,589 (+44.69%) | View |
| 2020-02-10 07:32 am Sale | 13G | LIGAND PHARMACEUTICALS INC LGND | BlackRock Inc. BLK | 2,385,158 13.6% | -376,703 (-13.64%) | View |
| 2020-01-10 5:10 pm Purchase | 13G | LIGAND PHARMACEUTICALS INC LGND | JANUS HENDERSON GROUP PLC JHG | 1,847,210 10.5% | 1,847,210 (New Position) | View |